Compare · DOX vs IQV
DOX vs IQV
Side-by-side comparison of Amdocs Limited (DOX) and IQVIA Holdings Inc. (IQV): market cap, price performance, sector, and recent activity on the wire.
Summary
- DOX operates in Technology, while IQV operates in Health Care - the two are in different parts of the market.
- IQV is the larger of the two at $28.00B, about 5.0x DOX ($5.56B).
- Over the past year, DOX is down 44.0% and IQV is up 8.1% - IQV leads by 52.1 points.
- IQV has been more active in the news (7 items in the past 4 weeks vs 2 for DOX).
- IQV has more recent analyst coverage (25 ratings vs 7 for DOX).
- Company
- Amdocs Limited
- IQVIA Holdings Inc.
- Price
- $51.48-6.31%
- $167.84-1.66%
- Market cap
- $5.56B
- $28.00B
- 1M return
- -17.10%
- -3.13%
- 1Y return
- -43.99%
- +8.12%
- Industry
- EDP Services
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NASDAQ
- NYSE
- IPO
- 2013
- News (4w)
- 2
- 7
- Recent ratings
- 7
- 25
Amdocs Limited
Amdocs Limited, through its subsidiaries, provides software and services to the communications, cable and satellite, entertainment, and media industry service providers worldwide. The company offers a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support and operations, such as end-to-end systems integration, managed, testing, cloud, digital business operations, and consulting services that addresses service providers business imperatives, including consumer experience and monetization, media and digital services, enterprise and connected society, open cloud networks, new domains and disruptions, and services and hybrid operations. It also provides revenue guard services designed to detect and resolve revenue leakage, fraud, and cyber fraud; and the BriteBill, a multi-channel bill presentment platform. In addition, the company offers advertising and media services for media publishers, TV networks, video streaming providers, advertising agencies, and service providers. Amdocs Limited was founded in 1988 and is headquartered in Chesterfield, Missouri.
IQVIA Holdings Inc.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Latest DOX
- New insider Rozenfeld Tal claimed ownership of 22,743 units of Ordinary Shares (SEC Form 3)
- Officer Smith Matthew E. sold $29,005 worth of Ordinary Shares (464 units at $62.51), decreasing direct ownership by 23% to 1,550 units (SEC Form 4)
- SEC Form 6-K filed by Amdocs Limited
- Officer Hortig Shimie was granted 84,483 units of Ordinary Shares, increasing direct ownership by 87% to 181,696 units (SEC Form 4)
- Amdocs Announces Third Quarter 2026 Investor Conference Schedule
- SEC Form 6-K filed by Amdocs Limited
- Amdocs Entitlement Server Sets New Industry Performance Benchmark on Microsoft Azure
- Lumen Technologies Accelerates Cloud-First Strategy with Amdocs, Expands Migration of Enterprise Billing Platform to Microsoft Azure
- Amdocs Announces Availability of Telco Agents for Customer Experience in Google's Gemini Enterprise Agent Marketplace
- Qué tal Móvil Selects Amdocs connectX to Launch Multi-Aggregator MVNO Platform, Accelerating Time to Market
Latest IQV
- IQVIA downgraded by Morgan Stanley with a new price target
- Wiley and IQVIA Release Cross-Sector Report on AI's Promise and Pressure Points Across Healthcare Value Chain
- IQVIA Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
- SEC Form 8-K filed by IQVIA Holdings Inc.
- IQVIA Announces Pricing of Senior Notes
- SEC Form 8-K filed by IQVIA Holdings Inc.
- IQVIA Announces Offering of Senior Notes
- IQVIA CEO to Speak at Jefferies Global Healthcare Conference
- IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities
- SEC Form 4 filed by Director Wims Morris Leslie